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Effect of U-50,488 H on the Development of Drug Craving Behavioral and Protection of
Morphological Change in Prefrontal Cortex, Thalamus and Amygdale of the Mice ( Mus
musculus) In the Morphine-Induced Dependence
Aniek Setiya Budiatin, Twoti Dika Parmanasari, Uswatun Khasanah, Junaidi Khotib
Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya
Repeated treatment of morphine produces several change in brain and behavior that far outlast their initial
neuropharmacological effects. The nature of persistent drug-induced neural plasticity is interested because it is thought to
contribute to the development of drug dependency and addiction. The purpose of this study was designed to investigate the
effect administration of a selective K-opioid reseptor agonist (U-50,488H) on rewarding effect associated with morphine
in mice and the neuron morphological change on the several brain region (PFC,thalamus and basolateral amygdala). An
unbiased conditioned place preference was developed to evaluate the rewarding effect of morphine in this animals. Drug
craving model was induced by subcutant injection of morphine at 3 mg/kg BW( based on previous study) oncea day forsix
altermately days. Various doses U-50.488H ( 0.1 mg/kg; l.Omg/kg; 3mg/kgBW) was administered by subcutant injection
pretreatment with morphine. The data showed that rewarding effect of morphine was strongly suppressed by pretreatment
U-50,488H and significantly attenuated at dose 0.1 mg/kg (Flt4t) = 14.024;p<0.05). The brain tissue was harvested onday
11 and sliced stereotaxically on PTC, thalamus and basolateral amygdale. The slicing was stained with routine histology
staining, hematoxyllin eosin for morphological qualitative analysis. The result showed that U-50.488H restore neuron
morphology in theseveral brain region (PFC, thalamusand basolateralamygdale) induced by morphine.
Keywords : Conditioned Place Preference; drug craving; morphine; PFC, thalamus and basolateral
amygdale; U-50.488H
INTRODUCTION
There are three major features of addictive behavior
need to be explained by any adequate theory drug
addiction. The first is drug craving by which the simply
mean intensely 'wanting' drugs. The second drug craving
often persists or can be reinstated, long after the
discontinuation of drug use. An understanding of the
propensity to relapse will be critical not only for
understanding the process of addiction, but in developing
effective therapies. A third feature of drug addiction that
requires explanation is that, as drugs come to be 'wanted'
more-and-more, they often come to be 'liked' less-and-
less. That is, as craving for drugs increases the pleasure
derived from drugs often decreases. Why is this? What is
the relationship between 'wanting' drugs and 'liking' drugs
and does this relationship change during addiction?
(Robinson1993).
The central feature of drug addiction is compulsive drug
use— loss of control over apparently voluntary acts of
drug seeking and drug taking (Glare, 1991).Addiction is a
chronic disorder, since even after treatment and extended
periods of drug abstinence, the risk of relapse to active
drug use remains high. In this review, we consider some
molecular mechanisms and neural circuits that may be
involved in persistent, compulsive drug abuse. We do not
attempt to provide a comprehensive account of the
numerous effects of addictive drugs on the brain Another
approach, which has been explored for potential
treatments of stimulant abuse, is the use of K- opioid
agonists. The tc- receptor is known to be involved, via
indirect effects, in synaptic dopamine levels (Figure 1).
This review covers several classes of K-opioid ligands that
have been explored for this purpose (Prisinzano, 2005).
Repeated treatment of morphine produces several
changes in brain and behavior that far outlast their initial
neuropharmacological effects. The nature of persistent
drug-induced neural plasticity is interested because it is
thought to contribute to the development of drug
dependency and addiction. The purpose of this study was
designed to investigate the effect of administration of a
selective K-opioid reseptor agonist (U-50.488H) on
rewardingeffect associated with morphine in miceand the
neuron morphological change of the several brain region
(PFC; thalamus and basolateral amygdala). An unbiased
conditioned place preference was developed to evaluate
the rewardingeffect of morphine in these animals
Objective
The purpose of this study was to investigate the effect of
administration of a selective K-opioid receptor agonist (1
S-trans)-3,4-dichloro-N-MethyI-N-[2-(l-pyrrolidinyl)-
cyclohexyljbenzeneacetamide hydrochloride [(- U-50,
488H] on rewarding effect and structural changes of
dopaminergic neurons associated with chronic morphine
treatment in mice. Male balb/C mice (weighing 25-30 g)
was adapted into three consecutive phases of unbiased
CPP procedure. Male mice; genus Mus, subfamili
Murinae, famili Muridae, ordo Rodentia, spesies Mus
musculus
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Figure 1. Treatment strategys for opioid dependence
MATERIALSAND METHODS
Materials
CPP box, microtome, Rotarod (UGO Basile, Italia),
microscope, microbalance , stopwatch, morphine
HC1 (PT. Kimia Farma, pharmaceutical grade), lithium
carbonate, U-50.488H (Sigma, analytical grade),
haematoxyline eosin, normal saline steril, ether, aqua pro
injection, paraffin, neutral buffered formalin, 1%-acidic
alcohol.
the preference of each individual mice (Figure 2). On
conditioning phase, these animals alternately received a
single injection s.c of saline, morphine 3.0 mg/kg, or
pretreatment of various dose of U-50.488H (0.1mg/kg;
1.0 mg/kg; 3.0 mg/kg) and were confined to the
compartment for 60-min. On post-conditioning, test day
was evaluated to determine compartment preferences
(Bardo, M.T, 2000). In this study, the sedative effect of
administration morphine and pretreatment U-50.488H
was measured using a RotaRod apparatus for a 60-sec
period. To evaluate the effect of administration morphine
and pretreatment U-50.488H at the projection of
dopaminergic neuron especially at basolateral amygdala
and thalamus, the brains were sliced 5 pm tight then were
stained by hematoxyline eosin and identified by light
microscope.
Methods
Male Balb/C mice (weighing 25-30 g) was adapted into
three consecutive phases of unbiased CPP procedure. On
pre-conditioning phase, mice were allowed to freely
explore all of the compartments fora900-sec period to see
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Figure 2 Pre-conditioning (a) and post - conditioning (b)
RESULTSAND DISCUSSION
The data showed that the rewarding effect of morphine
wassuppressed by pretreatment ofU-50.488H (0.1mg/kg;
1.0 mg/kg; 3.0 mg/kg, s.c) with morphine and was
significantly attenuated at dose 0.1 mg/kg respectively
(F(4, 48) = 14.024; p < 0.05) (Table 1). Both U-50.488H
and morphine had no significant difference on sedative
effect in mice (Table 2). Administration of chronic
morphine resulted structural changes at the region include
reduction of cells size, quantity of the cells, and
morphological changes. In line with its ability to suppress
the rewarding effect of morphine, the change in those
brain regions was prevented by the concomitant
pretreatment of selective K-opioid receptor agonist, U-
50.488H (Figure3and figure4).
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Table 1. Score CPP (second) for morphin group vs U-50.488H
Group ScorCPP (Mean±SE)
Negative Control
Morphin 3 .00 mg/kg BB
U50.488H 0.1 Omg/kgBB
U50.488H 1 .00 mg/kg BB
U50,488H 3 ,00 mg/kg BB
45.27 ± 20.48
167.25 ±31.68
-5.18 ± 27.64
-93.25 ± 23.63
-64.91 ±26.94
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Figure 3.Basolateral amygdala (BLA) with hematoxyllin eosin staining, (a)Control; (b) morphine, (c) U-
50.488H 0.1 mg/kg,(d) U-50.488H 1 mg/kg, (e) U-50,488H 3 mg/kg;400x normal size.
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Figure 4. Talamus with hematoxyllin eosin staining, (a) Control; (b) morphine, (c) U-50.488H 0.1 mg/kg, (d)
U-50.488H 1 mg/kg, (e) U-50.488H 3 mg/kg ; 400x normal size
WgaSsImmk
Table 2. The influence of U-50.488H treatment to the mice's coordination function. There were no significant difference
with ANOVAone way direction analysis ; F (4,41) =0,891;(p<0.05).
Group Resist ance time (seconds) (Mean ± SE)
Morphine 3.00 mg/kg
U-50.488H 0.10 mg/kg
U-50,488H 1.00 mg/kg
- U 50.488H 3.00 mg/kg
60.00± 0.00
60.00± 0.00
60.00± 0.00
58.56 ±4.33
The opioid p receptor activation provided the increased
locomotor, euphoria effect and drug craving, which the
opoid K receptor showed the disphoria, psycotomimetic
effect, sedative and drug refused (Narita et al, 2003;
Khotib et al). The result was showed the effect of
administration of a selective K-opioid reseptoragonist (U-
50.488H)on rewarding effect associated with morphine in
mice and the neuron morphological change of the several
brain region (PFC, thalamus and basolateral amygdala).
Administration of chronic morphine resulted structural
changes at the region include reduction of cells size,
quantity of the cells, and morphological changes ( Figure
3b and figure 4b) and selective K-opioid reseptor agonist
(U-50,488H) inhibited the morphology changes and cell
size( Figure 3 c;3dand figure4c ;4d)
Conclusion
The present study clearly demonstrate that K-opioid
receptor agonist U-50.488H might be a value in the
treatment and prevention of relapse to drug craving
behavior associated with morphine, and also prevent the
remodelingof morphological neurons that associated with
rewarding process.
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